Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.

@article{Bohorquez2017SafetyAO,
  title={Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.},
  author={Humberto E. Bohorquez and John B. Seal and Ari Cohen and Adam M. Kressel and Emily Bugeaud and Donald S. Bruce and Ian C. Carmody and Trevor W Reichman and Naren Battula and Mohammed Ubaid Alsaggaf and George Therapondos and Natalie H. Bzowej and Graham Tyson and Shobha N. Joshi and Ramona Nicolau-Raducu and Nigel Girgrah and George E. Loss},
  journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  year={2017},
  volume={17 8},
  pages={
          2155-2164
        }
}
Donation after circulatory death (DCD) liver transplantation (LT) reportedly yields inferior survival and increased complication rates compared with donation after brain death (DBD). We compare 100 consecutive DCD LT using a protocol that includes thrombolytic therapy (late DCD group) to an historical DCD group (early DCD group n = 38) and a cohort of DBD LT recipients (DBD group n = 435). Late DCD LT recipients had better 1- and 3-year graft survival rates than early DCD LT recipients (92% vs… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 9 times. VIEW TWEETS